Voxelotor
RxNorm 2265678
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2265678 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: voxelotor.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
FN
Full form of descriptor (FN):
Product containing voxelotor (medicinal product)
(Atom ID: 12421897)
IN
Ingredient (IN):
Voxelotor
(Atom ID: 12251524)
PT
Designated preferred name (PT):
Voxelotor
(Atom ID: 12422313)
FN
Full form of descriptor (FN):
Voxelotor (substance)
(Atom ID: 12422314)
PT
Designated preferred name (PT):
Voxelotor-containing product
(Atom ID: 12422317)
Patient Education
Voxelotor
Voxelotor is used to treat sickle cell disease (an inherited blood disease) in adults and children 12 years of age and older. Voxelotor is in a class of medications called hemoglobin S (HbS) polymerization inhibitors. It works by helping hemoglobin (a protein in red blood cells) to hold onto more oxygen and to stop red blood cells from becoming misshapen.
[Learn More]
* Please review the disclaimer below.